An Open-Label Safety and Blood Collection Study in MnB rLP2086 Vaccinated Healthy Adult Volunteers for Immunological Assay Development.
Phase of Trial: Phase I/II
Latest Information Update: 22 Aug 2011
At a glance
- Drugs PF 5212366 (Primary)
- Indications Meningococcal group B infections
- Focus Adverse reactions
- 01 Jul 2010 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
- 01 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Dec 2008 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.